2018 annual financial data
Cogent Biosciences 2018 Operating margin
Cogent Biosciences 2018 operating margin with verified reported values.
Direct answer
Operating margin was -369.89%.
Operating income was -36,005,000 USD and net income was -34,532,000 USD.
Operating cash flow was -32,489,000 USD.
Get free Cogent Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 9,734,000 USD
- Operating income
- -36,005,000 USD
- Net income
- -34,532,000 USD
- Operating cash flow
- -32,489,000 USD